Fenestrated AAA Endovascular Graft Post-Approval Study

Status:	Active, not recruiting
Conditions:	Cardiology, Cardiology, Cardiology
Therapuetic Areas:	Cardiology / Vascular Diseases
Healthy:	No
Age Range:	18 - Any
Updated:	1/19/2019
Start Date:	March 2014
End Date:	August 2020

Evaluation of the Long-term Safety and Performance of the Zenith® Fenestrated AAA Endovascular Graft Post-Approval Study

This post-market study is approved by the US FDA to evaluate the long-term safety and
performance of the Zenith® Fenestrated AAA Endovascular Graft.

Inclusion Criteria:

- abdominal aortic and aortoiliac aneursyms with a diameter greater than or equal to 5
cm

- aortic or aortoiliac aneurysm with a history of growth greater than or equal to 0.5 cm
per year, or clinical indication for AAA repair

Exclusion Criteria:

- proximal neck less than 4mm or greater than or equal to 15 mm in length unless
otherwise compromised to preclude seal

- renal artery stenosis greater than 50 percent

We found this trial at

sites

University of California-Davis

1 Shields Ave
Sacramento, California 95616

(530) 752-1011